Joint Ventures Reduce the Risk of Major Capital Investments
Harvard Business Review
APRIL 6, 2016
For instance, the cost of building and equipping a leading-edge semiconductor fab has climbed to $7 billion, as the technology required to make more advanced chips is getting more complex. Building a large-scale biopharmaceutical facility requires up to $500 million. This all presents CEOs with a tough dilemma.
8 
Let's personalize your content